LEVIN CAPITAL STRATEGIES, L.P. - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 162 filers reported holding INOVIO PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.

Quarter-by-quarter ownership
LEVIN CAPITAL STRATEGIES, L.P. ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$49,000
-56.2%
15,000
-50.0%
0.01%
-61.5%
Q1 2019$112,000
+0.9%
30,000
+50.0%
0.01%
+550.0%
Q3 2018$111,000
-23.4%
20,000
-45.9%
0.00%
-33.3%
Q2 2018$145,000
+49.5%
37,000
+80.5%
0.00%
+50.0%
Q1 2018$97,000
-71.2%
20,500
-61.4%
0.00%
-66.7%
Q3 2017$337,000
+83.2%
53,100
+126.0%
0.01%
+100.0%
Q2 2017$184,000
+85.9%
23,500
+56.7%
0.00%
+50.0%
Q1 2017$99,00015,0000.00%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Round Table Services, LLC 129,500$1,207,0000.72%
STONERIDGE INVESTMENT PARTNERS LLC 252,376$2,352,0000.34%
Bellevue Group AG 155,000$1,445,0000.26%
WASATCH ADVISORS LP 1,861,553$17,350,0000.26%
Blue Clay Capital Management, LLC 13,000$121,0000.14%
Virtus ETF Advisers LLC 24,058$224,0000.11%
EMERALD ADVISERS, LLC 203,737$1,899,0000.08%
Vident Investment Advisory, LLC 63,383$591,0000.08%
Thomas J. Herzfeld Advisors, Inc. 15,000$140,0000.08%
GSA CAPITAL PARTNERS LLP 94,400$880,0000.05%
View complete list of INOVIO PHARMACEUTICALS INC shareholders